PURPLE BIOTECH LTD. (PPBT) SEC Filings & Financial Intelligence
PURPLE BIOTECH LTD. (PPBT) is a publicly traded company on the Nasdaq, categorized under SIC 2834 (Pharmaceutical Preparations). Access real-time SEC filings, 10-K annual reports, 10-Q quarterlies, 8-K current reports, PCAOB auditor history, and executive compensation disclosures.
Ticker: PPBT
CIK: 1614744
Exchange: Nasdaq
SIC 2834: Pharmaceutical Preparations
Fiscal Year End: 12/31
State: L3
Independent PCAOB Auditor
Explore PCAOB Audit Intelligence →
Audit Firm
Somekh Chaikin
Auditor SinceSince 12/31/2016 12:00:00 AM
Lead Engagement PartnerNechama Shofnos
Audit LocationTel Aviv, Israel
Latest SEC EDGAR Filings
Showing 10-K, 10-Q, 8-K, Form 4, and other SEC submissions| Form | Filing Date | Reporting Period | Description | Accession Number | Actions |
|---|---|---|---|---|---|
| 6-K | 2026-10-05 | 2026-10-05 | REPORT OF FOREIGN PRIVATE ISSUER | 0001213900-26-106852 | View SEC Doc Filr Page |
| 6-K | 2026-09-09 | 2026-09-09 | REPORT OF FOREIGN PRIVATE ISSUER | 0001213900-26-098378 | View SEC Doc Filr Page |
| 6-K | 2026-09-02 | 2026-09-02 | REPORT OF FOREIGN PRIVATE ISSUER | 0001213900-26-096443 | View SEC Doc Filr Page |
| SCHEDULE 13G/A | 2026-08-14 | — | SCHEDULE 13G/A Filing | 0001446580-26-000101 | View SEC Doc Filr Page |
| 6-K | 2026-08-10 | 2026-08-10 | REPORT OF FOREIGN PRIVATE ISSUER | 0001213900-26-087226 | View SEC Doc Filr Page |
| 6-K | 2026-08-07 | 2026-08-07 | REPORT OF FOREIGN PRIVATE ISSUER | 0001213900-26-086393 | View SEC Doc Filr Page |
| 6-K | 2026-07-29 | 2026-07-29 | REPORT OF FOREIGN PRIVATE ISSUER | 0001213900-26-082792 | View SEC Doc Filr Page |
| 6-K | 2026-06-23 | 2026-06-23 | REPORT OF FOREIGN PRIVATE ISSUER | 0001213900-26-070884 | View SEC Doc Filr Page |
| 6-K | 2026-06-11 | 2026-06-11 | REPORT OF FOREIGN PRIVATE ISSUER | 0001213900-26-067548 | View SEC Doc Filr Page |
| F-3 | 2026-05-20 | — | REGISTRATION STATEMENT | 0001213900-26-059665 | View SEC Doc Filr Page |
| 6-K | 2026-05-15 | 2026-05-15 | REPORT OF FOREIGN PRIVATE ISSUER | 0001213900-26-057119 | View SEC Doc Filr Page |
| SCHEDULE 13G/A | 2026-05-13 | — | SCHEDULE 13G/A Filing | 0001213900-26-055837 | View SEC Doc Filr Page |
| 6-K | 2026-04-27 | 2026-04-27 | REPORT OF FOREIGN PRIVATE ISSUER | 0001213900-26-047709 | View SEC Doc Filr Page |
| 6-K | 2026-04-23 | 2026-04-23 | REPORT OF FOREIGN PRIVATE ISSUER | 0001213900-26-046868 | View SEC Doc Filr Page |
| 3 | 2026-04-17 | 2026-03-18 | 3 Filing | 0001213900-26-044999 | View SEC Doc Filr Page |
| 3 | 2026-04-07 | 2026-03-18 | 3 Filing | 0001213900-26-040968 | View SEC Doc Filr Page |
| 3 | 2026-04-06 | 2026-03-18 | 3 Filing | 0001213900-26-040511 | View SEC Doc Filr Page |
| 3 | 2026-03-31 | 2026-03-18 | 3 Filing | 0001213900-26-036868 | View SEC Doc Filr Page |
| 3/A | 2026-03-30 | 2026-03-18 | 3/A Filing | 0001213900-26-036407 | View SEC Doc Filr Page |
| 3 | 2026-03-30 | 2026-03-18 | 3 Filing | 0001213900-26-036361 | View SEC Doc Filr Page |
| 3 | 2026-03-27 | 2026-03-18 | 3 Filing | 0001213900-26-035282 | View SEC Doc Filr Page |
| 6-K | 2026-03-25 | 2026-03-25 | REPORT OF FOREIGN PRIVATE ISSUER | 0001213900-26-033843 | View SEC Doc Filr Page |
| 6-K | 2026-03-19 | 2026-03-18 | REPORT OF FOREIGN PRIVATE ISSUER | 0001213900-26-031366 | View SEC Doc Filr Page |
| 20-F | 2026-03-19 | 2025-12-31 | ANNUAL REPORT | 0001213900-26-031365 | View SEC Doc Filr Page |
| 3 | 2026-03-18 | 2026-03-18 | OWNERSHIP DOCUMENT | 0001213900-26-031048 | View SEC Doc Filr Page |